Neuropeptide and enteroendocrine signal

Neurotensin

Neurotensin is a peptide studied in the brain and intestine. Its relationships with intake and fat absorption cannot be summarized by a single direction of body-weight change in research models.

This is a research reference, not a product offered in the Asciende catalog. Published studies do not establish the identity, purity or availability of a commercial preparation.

Local signaling and experimental context

Record where and how the measurement was made. Presence of a peptide in a system does not establish that a commercial preparation reproduces that system.

Does the work study an isolated molecule, endogenous secretion or a preparation containing several components?
Are tissue, species and response measurement specified?
Does the interpretation distinguish signal detection from demonstration of its function in that model?

Find readings for this question

Mechanism described in the literature

In mice and intestinal cells, one study linked neurotensin, NTR1 and NTR3 receptors and AMPK signaling to fatty acid absorption. Another rodent investigation examined circuits and feeding responses after peripheral exposure.

Other names in the literature

Neurotensin
NT
NTS

Intestinal absorption and food intake

The 2016 high-fat-diet study combined neurotensin-deficient animals, cells and other approaches. Deficiency was accompanied by lower intestinal fat absorption. That outcome does not measure how much an animal chooses to eat and must remain separate from appetite tests (PMID 27193687).

A different result in the feeding model

Another study that year observed lower intake after peripheral neurotensin exposure in mice and rats. It also examined antagonism, neuronal markers and a PEGylated variant. Absorption, consumption and peptide modification are different processes, resolving the apparent tension between the experiments (PMID 27580810).

Pro-neurotensin is not the active peptide

The absorption study also included human observations of pro-neurotensin, a precursor fragment used as a marker. Those associations are not a neurotensin exposure experiment. The circulating marker, mature peptide and PEGylated variant require separate names when comparing findings or describing analyzed material.

Questions and answers

Do the fat-absorption and intake results necessarily contradict each other?

No. They describe distinct processes using different designs and variables.

Does the PEGylated variant establish the duration of the unmodified peptide?

No. The modification is part of the experimental material and the study question.